New York Life Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,979
| Closed | -$374K | – | 1269 |
|
|
2024
Q1 | $374K | Buy |
10,979
+1,374
| +14% | +$46.9K | ﹤0.01% | 897 |
|
|
2023
Q4 | $278K | Sell |
9,605
-222
| -2% | -$6.43K | ﹤0.01% | 1244 |
|
|
2023
Q3 | $271K | Sell |
9,827
-1,548
| -14% | -$42.7K | ﹤0.01% | 1217 |
|
|
2023
Q2 | $342K | Sell |
11,375
-1,704
| -13% | -$51.2K | ﹤0.01% | 1181 |
|
|
2023
Q1 | $474K | Sell |
13,079
-4,472
| -25% | -$162K | 0.01% | 1023 |
|
|
2022
Q4 | $626K | Buy |
17,551
+1,882
| +12% | +$67.1K | 0.01% | 743 |
|
|
2022
Q3 | $530K | Buy |
15,669
+1,240
| +9% | +$41.9K | 0.01% | 708 |
|
|
2022
Q2 | $417K | Buy |
+14,429
| New | +$417K | ﹤0.01% | 908 |
|